Skip to main content
TipRanks
Go Ultimate75% OFF

Robert Butchofsky Insider Profile

4 Followers

Robert Butchofsky, former President & CEO, Director at Novelion Therapeutics, holds 168.85K shares in Novelion Therapeutics (Ticker: NVLNF).

Robert Butchofsky's Trading History

NVLNF
Novelion Therapeutics
Mar 21, 2012―Uninformative Buy―$118.53K
NVLNF
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 21, 2012Uninformative Buy$0.00350$0.00―
Nov 08, 2010Informative Buy$16.87K3,000$5.62+25.10%
Jun 23, 2010Informative Buy$28.75K5,000$5.75+21.90%
Apr 07, 2010Uninformative Buy$0.001,400$0.00―
Nov 04, 2009Informative Buy$33.99K10,000$3.39+68.80%

You May Also Like

Robert Butchofsky insider profile FAQ

What is the percentage of profitable transactions made by Robert Butchofsky?
The percentage of profitable transactions made by Robert Butchofsky is 100%.
What is the average return per transaction made by Robert Butchofsky?
The average return per transaction made by Robert Butchofsky is 72.60%.
What stocks does Robert Butchofsky hold?
Robert Butchofsky holds: NVLNF stocks.
What was Robert Butchofsky's most profitable transaction?
Robert Butchofsky’s most profitable transaction was an Informative Buy of NVLNF stock on February 24, 2009. The return on the trade was 174.70%.
What is Robert Butchofsky's role in Novelion Therapeutics?
Robert Butchofsky's role in Novelion Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.